Gritstone Oncology focuses on cancer drugs—presently in pre-clinical trials. This focus is an extremely risky proposition, given the effort, cost, length of time and complexity that lies ahead as they move toward clinical trials. Read Seeking Alpha’s Donovan Jones for a nice summary of the situation for investors.

Source: Seeking Alpha

Pin It on Pinterest